Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups

被引:20
|
作者
Parsian, A
Racette, B
Zhang, ZH
Rundle, M
Perlmutter, JS
机构
[1] Univ Louisville, Hlth Sci Ctr, Dept Mol & Cellular Biol, Louisville, KY 40292 USA
[2] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63110 USA
关键词
Parkinson; monoamine oxidases A and B; genetics; polymorphism;
D O I
10.1016/j.ygeno.2003.09.002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Idiopathic Parkinson's disease (PD) is an age dependent, neurodegenerative disorder and is predominantly a sporadic disease. A minority of patients has a positive family history for PD and the majority of those families exhibit a complex mode of inheritance. The monoamine oxidases A and B (MAO-A and -B) genes, which are involved in serotonin and dopamine metabolism, are possible candidate genes for susceptibility to PD. Previous association studies of MAO-A and -B in PD have been inconclusive. To determine the role of MAO-A and -B in the development of PD, we screened a sample of 96 patients with familial PD, 164 with sporadic PD, and 180 matched normal controls with dinucleotide repeat markers in these genes. MAO-A and -B gene polymorphisms were strongly associated with total PD (p<0.00001), familial PD (p<0.00001), and sporadic PD (p<0.00001). There were no significant differences between familial or sporadic PD with age of onset younger than 50 years compared to those with age of onset older than 51 years for both MAO-A and -B genes. There was no linkage disequilibrium between these genes in male PD and control groups. The frequency of common haplotypes from MAO-A and -B was different in PD and control group (p = 0.02). Our data indicate that MAO-A and -B may play a role in susceptibility to PD in our sample. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:454 / 460
页数:7
相关论文
共 50 条
  • [41] Altered Platelet Monoamine Oxidase-B Activity in Idiopathic Parkinson's Disease
    Husain, Maroof
    Shukla, Rakesh
    Dikshit, Madhu
    Maheshwari, Pradeep K.
    Nag, Devika
    Srimal, Rikhab C.
    Seth, Prahlad K.
    Khanna, Vinay K.
    NEUROCHEMICAL RESEARCH, 2009, 34 (08) : 1427 - 1432
  • [42] Exploring the Association between Cathepsin B and Parkinson's Disease
    Lu, Changhao
    Cai, Xinyi
    Zhi, Shilin
    Wen, Xiaofen
    Shen, Jiaxin
    Ercoli, Tommaso
    Simula, Elena Rita
    Masala, Carla
    Sechi, Leonardo A.
    Solla, Paolo
    BRAIN SCIENCES, 2024, 14 (05)
  • [43] Monoamine oxidase-B (MAO-B) inhibitors: Implications for disease-modification in Parkinson's disease
    Teo K.C.
    Ho S.-L.
    Translational Neurodegeneration, 2 (1)
  • [44] NADPH oxidases 2 activation in patients with Parkinson's disease
    Marrali, G.
    Casale, F.
    Salamone, P.
    Fuda, G.
    Ilardi, A.
    Manera, U.
    Calvo, A.
    Zibetti, M.
    Lopiano, L.
    Chio, A.
    PARKINSONISM & RELATED DISORDERS, 2018, 49 : 110 - 111
  • [45] Substrate specificity of human platelet monoamine oxidase B activity in Parkinson's and Alzheimer's disease
    Fitzgerald, DH
    Tipton, KF
    Anderson, MC
    Lawlor, B
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1996, 24 (01) : S63 - S63
  • [46] Monoamine oxidases A and B gene polymorphisms in migraine patients
    Filic, V
    Vladic, A
    Stefulj, J
    Cicin-Sain, L
    Balija, M
    Sucic, Z
    Jernej, B
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 228 (02) : 149 - 153
  • [47] Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population
    Hao, Hongying
    Shao, Ming
    An, Jing
    Chen, Chushuang
    Feng, Xiuli
    Xie, Shu
    Gu, Zhuqin
    Chan, Piu
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (10) : 1041 - 1045
  • [48] Effect of lamotrigine on the activities of monoamine oxidases A and B in vitro and on monoamine disposition in vivo
    Southam, E
    Pereira, R
    Stratton, SC
    Sargent, R
    Ford, AJ
    Butterfield, LJ
    Wheable, JD
    Beckett, SRG
    Roe, C
    Marsden, CA
    Hagan, RM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 519 (03) : 237 - 245
  • [49] Profiling subgroups of cognitive performance in Parkinson's disease
    van Rooden, S.
    Verbaan, D.
    Visser, M.
    Marinus, J.
    Verduin, C. J.
    Heiser, W. J.
    van Hilten, J. J.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S187 - S187
  • [50] Berry anthocyanins and their aglycons inhibit monoamine oxidases A and B
    Dreiseitel, Andrea
    Korte, Gabriele
    Schreier, Peter
    Oehme, Anett
    Locher, Sanja
    Domani, Martina
    Hajak, Goeran
    Sand, Philipp G.
    PHARMACOLOGICAL RESEARCH, 2009, 59 (05) : 306 - 311